Affiliation:
1. I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)
Abstract
Systemic sclerosis (SSc) is a disease characterized by vasculopathy, fibrosis of the skin and internal organs, most often complicated by interstitial lung disease (ILD). The incidence of SSc reaches 20 cases per 1 million population per year, while changes in the lungs are found in more than half of patients and are characterized by a rapid increase in fibrosis, poorly controlled respiratory failure, and an unfavorable prognosis. It is important to trace the features of the formation and course of ILD and its relationship with occupational hazards in patients diagnosed with SSc. Dust pathology of the respiratory organs (chronic dust bronchitis and silicosis) is most typical for people with long work experience in mining. Silicosis in these patients may be accompanied by SSc with rapid progression of bronchial obstruction, restrictive disorders, as well as myocardial involvement and the development of pulmonary hypertension.
Subject
Pharmacology (medical),Immunology,Immunology and Allergy,Rheumatology
Reference15 articles.
1. Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017 Oct 7;390(10103):1685-99. doi: 10.1016/S0140-6736(17)30933-9. Epub 2017 Apr 13.
2. Chuchalin AG, editor. Respiratornaya meditsina [Respiratory medicine]. Vol. 3. Moscow: Literra; 2017. P. 348.
3. Sigidin YaA, Guseva NG, Ivanova MM. Diffuznye bolezni soedinitel'noi tkani [Diffuse connective tissue diseases]. Moscow: Meditsina; 2004. P. 343-487.
4. Perelas A, Silver RM, Arrossi AV, Highland KB. Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med. 2020 Mar;8(3):304-20. doi:10.1016/S2213-2600(19)30480-1.
5. Abbot S, Bossingham D, Proudman S, et al. Risk factors for the development of systemic sclerosis: a systematic review of the literature. Rheumatol Adv Pract. 2018 Oct 11; 2(2):rky041. doi: 10.1093/rap/rky041.eCollection 2018.